Boothbay Fund Management’s Corbus Pharmaceuticals CRBP Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q1 | – | Sell |
-10,534
| Closed | -$124K | – | 1288 |
|
|
2024
Q4 | $124K | Sell |
10,534
-72,084
| -87% | -$851K | ﹤0.01% | 1098 |
|
|
2024
Q3 | $1.7M | Sell |
82,618
-3,731
| -4% | -$77K | 0.04% | 480 |
|
|
2024
Q2 | $3.91M | Sell |
86,349
-69,664
| -45% | -$3.15M | 0.09% | 250 |
|
|
2024
Q1 | $6.12M | Buy |
156,013
+114,398
| +275% | +$4.49M | 0.12% | 144 |
|
|
2023
Q4 | $251K | Hold |
41,615
| – | – | 0.01% | 1099 |
|
|
2023
Q3 | $280K | Buy |
41,615
+3,639
| +10% | +$24.5K | 0.01% | 1094 |
|
|
2023
Q2 | $298K | Hold |
37,976
| – | – | 0.01% | 1106 |
|
|
2023
Q1 | $276K | Buy |
37,976
+36,645
| +2,753% | +$266K | 0.01% | 1337 |
|
|
2022
Q4 | $4.41K | Hold |
1,331
| – | – | ﹤0.01% | 1695 |
|
|
2022
Q3 | $7K | Sell |
1,331
-1,831
| -58% | -$9.63K | ﹤0.01% | 1896 |
|
|
2022
Q2 | $24K | Sell |
3,162
-18
| -0.6% | -$137 | ﹤0.01% | 1909 |
|
|
2022
Q1 | $51K | Hold |
3,180
| – | – | ﹤0.01% | 1794 |
|
|
2021
Q4 | $59K | Hold |
3,180
| – | – | ﹤0.01% | 1601 |
|
|
2021
Q3 | $97K | Sell |
3,180
-1,098
| -26% | -$33.5K | ﹤0.01% | 1558 |
|
|
2021
Q2 | $235K | Buy |
4,278
+579
| +16% | +$31.8K | 0.01% | 1258 |
|
|
2021
Q1 | $219K | Buy |
3,699
+3,209
| +655% | +$190K | 0.01% | 1097 |
|
|
2020
Q4 | $18K | Buy |
+490
| New | +$18K | ﹤0.01% | 1037 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 947 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 859 |
|